Related Experiment Video
Updated: May 2, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administration
E R Wang1, A A Jarrah1, L Benard1
1Department of Medicine, Division of Cardiovascular Research Center, Mount Sinai School of Medicine, New York, NY, USA.
Insights
Stromal cell-derived factor-1α (SDF-1α) and its receptor CXCR4 protect against heart failure by modulating beta-adrenergic signaling. This pathway prevents hypertrophy and improves cardiac function, offering a potential therapeutic target.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Adrenergic Signaling
Background:
- Altered alpha- and beta-adrenergic receptor signaling contributes to cardiac hypertrophy and failure.
- Stromal cell-derived factor-1α (SDF-1α)/CXCR4 axis is known for stem cell mobilization and cardioprotection post-injury.
- The role of SDF-1/CXCR4 in acute protection against pathological hypertrophy and its mechanisms remain unclear.
Purpose of the Study:
- To investigate whether SDF-1/CXCR4 signaling confers acute protection against pathological cardiac hypertrophy.
- To elucidate the molecular mechanisms underlying SDF-1/CXCR4-mediated cardioprotection in the context of beta-adrenergic stimulation.
- To determine the impact of CXCR4 on beta-adrenergic receptor-induced cardiac dysfunction.
Main Methods:
- Utilized a mouse model with isoproterenol administration to induce cardiac hypertrophy.
- Employing Cre-loxP-mediated gene recombination to selectively abrogate CXCR4 expression in cardiomyocytes.
- Assessed cardiac function using fractional shortening and ejection fraction, and evaluated apoptosis and mitochondrial function.
- Investigated the therapeutic potential of CXCR4 gene transfer using adeno-associated viral-9 vectors.
Main Results:
- CXCR4 knockout mice exhibited exacerbated cardiac dysfunction, reduced fractional shortening and ejection fraction.
- Ablation of CXCR4 increased susceptibility to isoproterenol-induced heart failure, marked by elevated apoptotic markers and impaired mitochondrial function.
- CXCR4 gene transfer via AAV9 vectors improved mitochondrial function, reduced cardiac apoptosis, and restored cardiac function.
- CXCR4 expression was found to prevent beta-adrenergic receptor-induced hypertrophy.
Conclusions:
- SDF-1/CXCR4 signaling plays a critical role in mediating acute cardioprotection against pathological hypertrophy.
- CXCR4 modulates beta-adrenergic receptor signaling, thereby preventing cardiac hypertrophy and dysfunction.
- Targeting the SDF-1/CXCR4 pathway represents a promising therapeutic strategy for heart failure.
Abstract:
Altered alpha- and beta-adrenergic receptor signaling is associated with cardiac hypertrophy and failure. Stromal cell-derived factor-1α (SDF-1α) and its cognate receptor CXCR4 have been reported to mediate cardioprotection after injury through the mobilization of stem cells into injured tissue. However, little is known regarding whether SDF-1/CXCR4 induces acute protection following pathological hypertrophy and if so, by what molecular mechanism. We have previously reported that CXCR4 physically interacts with the beta-2 adrenergic receptor and modulates its downstream signaling. Here we have shown that CXCR4 expression prevents beta-adrenergic receptor-induced hypertrophy. Cardiac beta-adrenergic receptors were stimulated with the implantation of a subcutaneous osmotic pump administrating isoproterenol and CXCR4 expression was selectively abrogated in cardiomyocytes using Cre-loxP-mediated gene recombination. CXCR4 knockout mice showed worsened fractional shortening and ejection fraction. CXCR4 ablation increased susceptibility to isoproterenol-induced heart failure, by upregulating apoptotic markers and reducing mitochondrial function; cardiac function decreases whereas fibrosis increases. In addition, CXCR4 expression was rescued with the use of cardiotropic adeno-associated viral-9 vectors. CXCR4 gene transfer reduced cardiac apoptotic signaling, improved mitochondrial function and resulted in a recovered cardiac function. Our results represent the first evidence that SDF-1/CXCR4 signaling mediates acute cardioprotection through modulating beta-adrenergic receptor signaling in vivo.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure

